BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol. 2007;8:545-553. [PMID: 17540306 DOI: 10.1016/s1470-2045(07)70172-9] [Cited by in Crossref: 327] [Cited by in F6Publishing: 113] [Article Influence: 23.4] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Y, Wang Y, Shan L, Peng C, Zhang W, Zhao X. A network meta-analysis for neoadjuvant and adjuvant treatments for resectable squamous cell carcinoma of esophagus. Sci Rep 2021;11:6800. [PMID: 33762694 DOI: 10.1038/s41598-021-86102-8] [Reference Citation Analysis]
2 Meng J, Zhang C, Zhao T, Shi G, Zhao J, Lin Z. MicroRNA-210 targets FBXO31 to inhibit tumor progression and regulates the Wnt/β-catenin signaling pathway and EMT in esophageal squamous cell carcinoma. Thorac Cancer 2021;12:932-40. [PMID: 33538099 DOI: 10.1111/1759-7714.13860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Puntambekar S, Kenawadekar R, Kumar S, Joshi S, Agarwal G, Reddy S, Mallik J. Robotic transthoracic esophagectomy. BMC Surg 2015;15:47. [PMID: 25898903 DOI: 10.1186/s12893-015-0024-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
4 Yang J, Chen L, Ge K, Yang JL. Efficacy of hybrid minimally invasive esophagectomy vs open esophagectomy for esophageal cancer: A meta-analysis. World J Gastrointest Oncol 2019;11:1081-91. [PMID: 31798787 DOI: 10.4251/wjgo.v11.i11.1081] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Honda M, Daiko H, Kinoshita T, Fujita T, Shibasaki H, Nishida T. Minimally invasive resection of synchronous thoracic esophageal and gastric carcinomas followed by reconstruction: a case report. Surg Case Rep. 2015;1:12. [PMID: 26943380 DOI: 10.1186/s40792-015-0018-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
6 Sun WZ, Chen L, Yang X, Wang B, Deng XW, Huang XY. Comparison of treatment plan quality of VMAT for esophageal carcinoma with: flattening filter beam versus flattening filter free beam. J Cancer 2018;9:3263-8. [PMID: 30271485 DOI: 10.7150/jca.26044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Tsirlis TD, Papastratis G, Masselou K, Tsigris C, Papachristodoulou A, Kostakis A, Nikiteas NI. Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? World J Gastroenterol 2008;14:2691-701. [PMID: 18461654 DOI: 10.3748/wjg.14.2691] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
8 Hayashi Y, Iijima H, Isohashi F, Tsujii Y, Fujinaga T, Nagai K, Yoshii S, Sakatani A, Hiyama S, Shinzaki S, Makino T, Yamasaki M, Ogawa K, Doki Y, Takehara T. The heart's exposure to radiation increases the risk of cardiac toxicity after chemoradiotherapy for superficial esophageal cancer: a retrospective cohort study. BMC Cancer 2019;19:195. [PMID: 30832605 DOI: 10.1186/s12885-019-5421-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
9 Zheng C, Li XK, Zhang C, Zhou H, Ji SG, Zhong JH, Xu Y, Cong ZZ, Wang GM, Wu WJ, Shen Y. Comparison of short-term clinical outcomes between robot-assisted minimally invasive esophagectomy and video-assisted minimally invasive esophagectomy: a systematic review and meta-analysis. J Thorac Dis 2021;13:708-19. [PMID: 33717543 DOI: 10.21037/jtd-20-2896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Mariette C. Is there a place for esogastric cancer surgery in cirrhotic patients? Ann Surg Oncol 2008;15:680-2. [PMID: 18172733 DOI: 10.1245/s10434-007-9765-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
11 Shi M, Wang Z, Liu XY, Chen D. Inactivation of RUNX3 predicts poor prognosis in esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy. Med Oncol 2014;31:309. [PMID: 25391920 DOI: 10.1007/s12032-014-0309-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 Liu Y, Kou C, Su Y, Zhang Y, You Y, Zhang L, Wang M, Fu Y, Ren X, Yang Y. Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials. Onco Targets Ther 2017;10:2971-81. [PMID: 28652779 DOI: 10.2147/OTT.S137474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Yun JS, Na KJ, Song SY, Kim S, Jeong IS, Oh SG. Comparison of perioperative outcomes following hybrid minimally invasive versus open Ivor Lewis esophagectomy for esophageal cancer. J Thorac Dis. 2017;9:3097-3104. [PMID: 29221284 DOI: 10.21037/jtd.2017.08.49] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
14 Thar Min AK, Okayama H, Saito M, Ashizawa M, Aoto K, Nakajima T, Saito K, Hayase S, Sakamoto W, Tada T, Hanayama H, Saze Z, Momma T, Ohki S, Sato Y, Motoyama S, Mimura K, Kono K. Epithelial-mesenchymal transition-converted tumor cells can induce T-cell apoptosis through upregulation of programmed death ligand 1 expression in esophageal squamous cell carcinoma. Cancer Med 2018. [PMID: 29855157 DOI: 10.1002/cam4.1564] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
15 Zang R, Qiu X, Song Y, Wang Y. Exosomes Mediated Transfer of Circ_0000337 Contributes to Cisplatin (CDDP) Resistance of Esophageal Cancer by Regulating JAK2 via miR-377-3p. Front Cell Dev Biol 2021;9:673237. [PMID: 34307356 DOI: 10.3389/fcell.2021.673237] [Reference Citation Analysis]
16 Liu X, Zhao Y, Zhang W, Gao Y, Huo M, Liu M, Xiao Z, Liang S, Xu N, Zhu H. Inhibition of survivin enhances radiosensitivity of esophageal cancer cells by switching radiation-induced senescence to apoptosis. Onco Targets Ther 2018;11:3087-100. [PMID: 29872320 DOI: 10.2147/OTT.S166798] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 3.3] [Reference Citation Analysis]
17 Huang YC, Li SH, Lu HI, Hsu CC, Wang YM, Lin WC, Chen CJ, Ho KW, Chiu NT. Post-chemoradiotherapy FDG PET with qualitative interpretation criteria for outcome stratification in esophageal squamous cell carcinoma. PLoS One 2019;14:e0210055. [PMID: 30615636 DOI: 10.1371/journal.pone.0210055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
18 Li JJ, He LJ, Shan HB, Wang TD, Xiong H, Chen LM, Xu GL, Li XH, Huang XX, Luo GY, Li Y, Zhang R. Superficial esophageal lesions detected by endoscopic ultrasound enhanced with submucosal edema. World J Gastroenterol 2013;19:9034-42. [PMID: 24379628 DOI: 10.3748/wjg.v19.i47.9034] [Reference Citation Analysis]
19 He H, Wu Q, Wang Z, Zhang Y, Chen N, Fu J, Zhang G. Short-term outcomes of robot-assisted minimally invasive esophagectomy for esophageal cancer: a propensity score matched analysis. J Cardiothorac Surg 2018;13:52. [PMID: 29792203 DOI: 10.1186/s13019-018-0727-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
20 O'Callaghan C, Fanning LJ, Barry OP. p38δ MAPK phenotype: an indicator of chemotherapeutic response in oesophageal squamous cell carcinoma. Anticancer Drugs 2015;26:46-55. [PMID: 25099621 DOI: 10.1097/CAD.0000000000000156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
21 Chen SY, Molena D, Stem M, Mungo B, Lidor AO. Post-discharge complications after esophagectomy account for high readmission rates. World J Gastroenterol 2016;22:5246-53. [PMID: 27298567 DOI: 10.3748/wjg.v22.i22.5246] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
22 Yang X, Cai W, Yang Q, Lu Z, Li J, Yu J. Compound Radix Sophorae Flavescentis exerts antitumor effects by inhibiting the proliferation and inducing the apoptosis of esophageal carcinoma TE-8 cells. Oncol Lett 2015;10:2209-13. [PMID: 26622820 DOI: 10.3892/ol.2015.3607] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
23 Rolff HC, Ambrus RB, Belmouhand M, Achiam MP, Wegmann M, Siemsen M, Kofoed SC, Svendsen LB. Robot-Assisted Hybrid Esophagectomy Is Associated with a Shorter Length of Stay Compared to Conventional Transthoracic Esophagectomy: A Retrospective Study. Minim Invasive Surg. 2017;2017:6907896. [PMID: 29362674 DOI: 10.1155/2017/6907896] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
24 Hashimoto T, Kurokawa Y, Mori M, Doki Y. Surgical Treatment of Gastroesophageal Junction Cancer. J Gastric Cancer 2018;18:209-17. [PMID: 30275998 DOI: 10.5230/jgc.2018.18.e28] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
25 Bhat AA, Nisar S, Maacha S, Carneiro-Lobo TC, Akhtar S, Siveen KS, Wani NA, Rizwan A, Bagga P, Singh M, Reddy R, Uddin S, Grivel JC, Chand G, Frenneaux MP, Siddiqi MA, Bedognetti D, El-Rifai W, Macha MA, Haris M. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy. Mol Cancer 2021;20:2. [PMID: 33390169 DOI: 10.1186/s12943-020-01294-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
26 Reeh M, Nentwich MF, Asani S, Uzunoglu FG, Bockhorn M, Sauter G, Rösch T, Izbicki JR, Bogoevski D. Locally advanced esophageal carcinoma: is there still a role of surgery alone without neoadjuvant treatment? J Gastrointest Surg 2015;19:587-93. [PMID: 25652343 DOI: 10.1007/s11605-015-2762-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
27 Han L, Gao QL, Zhou XM, Shi C, Chen GY, Song YP, Yao YJ, Zhao YM, Wen XY, Liu SL, Qi YM, Gao YF. Characterization of CD103+ CD8+ tissue-resident T cells in esophageal squamous cell carcinoma: may be tumor reactive and resurrected by anti-PD-1 blockade. Cancer Immunol Immunother 2020;69:1493-504. [PMID: 32285170 DOI: 10.1007/s00262-020-02562-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
28 Kalita D, Bannoth S, Purkayastha J, Talukdar A, Das G, Singh P. A Study of Hormonal Receptors in Esophageal Carcinoma: Northeast Indian Tertiary Cancer Center Study. South Asian J Cancer 2020;9:222-6. [PMID: 34136423 DOI: 10.1055/s-0041-1729448] [Reference Citation Analysis]
29 Sudo N, Ichikawa H, Muneoka Y, Hanyu T, Kano Y, Ishikawa T, Hirose Y, Miura K, Shimada Y, Nagahashi M, Sakata J, Kobayashi T, Bamba T, Nakagawa S, Kosugi SI, Wakai T. Clinical Utility of ypTNM Stage Grouping in the 8th Edition of the American Joint Committee on Cancer TNM Staging System for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021;28:650-60. [PMID: 33025354 DOI: 10.1245/s10434-020-09181-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
30 Lordick F, Hölscher AH, Haustermans K, Wittekind C. Multimodal treatment of esophageal cancer. Langenbecks Arch Surg 2013;398:177-87. [PMID: 22971784 DOI: 10.1007/s00423-012-1001-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
31 Rashid F, Khan RN, Iftikhar SY. Probing the link between oestrogen receptors and oesophageal cancer. World J Surg Oncol. 2010;8:9. [PMID: 20146809 DOI: 10.1186/1477-7819-8-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
32 Song T, Zhang X, Fang M, Zhao R, Wu S. Long-term results of definitive concurrent chemoradiotherapy using paclitaxel plus oxaliplatin in unresectable locally advanced esophageal cancer: a prospective phase II trial. Cancer Med 2016;5:3371-7. [PMID: 27925455 DOI: 10.1002/cam4.897] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Liu JY, Li F, Wang LP, Chen XF, Wang D, Cao L, Ping Y, Zhao S, Li B, Thorne SH, Zhang B, Kalinski P, Zhang Y. CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma. Br J Cancer 2015;113:747-55. [PMID: 26284335 DOI: 10.1038/bjc.2015.290] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 8.3] [Reference Citation Analysis]
34 Kono K, Mimura K, Yamada R, Ujiie D, Hayase S, Tada T, Hanayama H, Min AKT, Shibata M, Momma T, Saze Z, Ohki S. Current status of cancer immunotherapy for esophageal squamous cell carcinoma. Esophagus 2018;15:1-9. [PMID: 29892809 DOI: 10.1007/s10388-017-0596-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
35 Koyanagi K, Kanamori K, Ninomiya Y, Yatabe K, Higuchi T, Yamamoto M, Tajima K, Ozawa S. Progress in Multimodal Treatment for Advanced Esophageal Squamous Cell Carcinoma: Results of Multi-Institutional Trials Conducted in Japan. Cancers (Basel) 2020;13:E51. [PMID: 33375499 DOI: 10.3390/cancers13010051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Engel S, Awerbuch A, Kwon D, Picado O, Yechieli R, Yakoub D, Portelance L. Optimal radiation dosing in concurrent neoadjuvant chemoradiation for resectable esophageal cancer: a meta-analysis. J Gastrointest Oncol 2019;10:391-9. [PMID: 31183187 DOI: 10.21037/jgo.2019.01.02] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
37 Zhang YH, Fischer MA, Lehmann H, Johnsson Å, Rouvelas I, Herlin G, Lundell L, Brismar TB. Computed tomography volumetry of esophageal cancer - the role of semiautomatic assessment. BMC Med Imaging 2019;19:17. [PMID: 30767773 DOI: 10.1186/s12880-019-0317-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Boone J, van Hillegersberg R, van Diest PJ, Offerhaus GJ, Rinkes IH, Kate FJ. Validation of tissue microarray technology in squamous cell carcinoma of the esophagus. Virchows Arch 2008;452:507-14. [PMID: 18392848 DOI: 10.1007/s00428-008-0602-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
39 Uzunoglu FG, Reeh M, Kutup A, Izbicki JR. Surgery of esophageal cancer. Langenbecks Arch Surg. 2013;398:189-193. [PMID: 23354360 DOI: 10.1007/s00423-013-1052-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
40 Vashist YK, Trump F, Gebauer F, Kutup A, Güngör C, Kalinin V, Muddasar R, Vettorazzi E, Yekebas EF, Brandt B, Pantel K, Izbicki JR. EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer. Target Oncol 2014;9:43-52. [PMID: 23377570 DOI: 10.1007/s11523-013-0260-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
41 Somashekhar SP, Jaka RC. Total (Transthoracic and Transabdominal) Robotic Radical Three-Stage Esophagectomy-Initial Indian Experience. Indian J Surg 2017;79:412-7. [PMID: 29089700 DOI: 10.1007/s12262-016-1498-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Njei B, McCarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis. J Gastroenterol Hepatol. 2016;31:1141-1146. [PMID: 26749521 DOI: 10.1111/jgh.13289] [Cited by in Crossref: 125] [Cited by in F6Publishing: 99] [Article Influence: 31.3] [Reference Citation Analysis]
43 Zhao C, Lin L, Liu J, Liu R, Chen Y, Ge F, Jia R, Jin Y, Wang Y, Xu J. A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma. Oncotarget 2016;7:57310-6. [PMID: 28087951 DOI: 10.18632/oncotarget.9809] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
44 Boonstra JJ, van Marion R, Tilanus HW, Dinjens WN. Functional polymorphisms associated with disease-free survival in resected carcinoma of the esophagus. J Gastrointest Surg 2011;15:48-56. [PMID: 20922573 DOI: 10.1007/s11605-010-1358-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
45 Wolf MC, Zehentmayr F, Schmidt M, Hölzel D, Belka C. Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre. Radiat Oncol 2012;7:60. [PMID: 22501022 DOI: 10.1186/1748-717X-7-60] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
46 Shi M, Wang Z, Song L, Wang D, Sun Z. Low expression of claudin-4: an indicator of recurrence in esophageal squamous cell carcinoma after Ivor Lewis esophagectomy? Med Oncol 2014;31:951. [PMID: 24737010 DOI: 10.1007/s12032-014-0951-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
47 Hu D, Zhang M, Wang S, Wang Z. High expression of cyclooxygenase 2 is an indicator of prognosis for patients with esophageal squamous cell carcinoma after Ivor Lewis esophagectomy. Thorac Cancer 2016;7:310-5. [PMID: 27148416 DOI: 10.1111/1759-7714.12329] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
48 Zhang JL, Wang HY, Yang Q, Lin SY, Luo GY, Zhang R, Xu GL. Methyl-methanesulfonate sensitivity 19 expression is associated with metastasis and chemoradiotherapy response in esophageal cancer. World J Gastroenterol 2015;21:4240-7. [PMID: 25892874 DOI: 10.3748/wjg.v21.i14.4240] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
49 Li JJ, Shan HB, He LJ, Wang TD, Xiong H, Chen LM, Li XH, Huang XX, Luo GY, Li Y, Xu GL. Extraesophageal saline enhances endoscopic ultrasonography to differentiate esophagus and adjacent organs. World J Gastroenterol 2014;20:12551-8. [PMID: 25253957 DOI: 10.3748/wjg.v20.i35.12551] [Reference Citation Analysis]
50 Zhu W, Xing L, Yue J, Sun X, Sun X, Zhao H, Yu J. Prognostic significance of SUV on PET/CT in patients with localised oesophagogastric junction cancer receiving neoadjuvant chemotherapy/chemoradiation: a systematic review and meta-analysis. Br J Radiol. 2012;85:e694-e701. [PMID: 22337686 DOI: 10.1259/bjr/29946900] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
51 Chen Y, Wu X, Bu S, He C, Wang W, Liu J, Guo W, Tan B, Wang Y, Wang J. Promising outcomes of definitive chemoradiation and cetuximab for patients with esophageal squamous cell carcinoma. Cancer Sci. 2012;103:1979-1984. [PMID: 22845557 DOI: 10.1111/j.1349-7006.2012.02393.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
52 van der Sluis PC, Ruurda JP, Verhage RJ, van der Horst S, Haverkamp L, Siersema PD, Borel Rinkes IH, Ten Kate FJ, van Hillegersberg R. Oncologic Long-Term Results of Robot-Assisted Minimally Invasive Thoraco-Laparoscopic Esophagectomy with Two-Field Lymphadenectomy for Esophageal Cancer. Ann Surg Oncol. 2015;22 Suppl 3:S1350-S1356. [PMID: 26023036 DOI: 10.1245/s10434-015-4544-x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 69] [Article Influence: 14.3] [Reference Citation Analysis]
53 Wang S, Xi J, Lin Z, Hao J, Yao C, Zhan C, Jiang W, Shi Y, Wang Q. Clinical values of Ku80 upregulation in superficial esophageal squamous cell carcinoma. Cancer Med 2018;7:1006-18. [PMID: 29532618 DOI: 10.1002/cam4.1314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Dermine S, Leconte M, Leblanc S, Dousset B, Terris B, Berger A, Berger A, Rahmi G, Lepilliez V, Plomteux O, Leclercq P, Coriat R, Chaussade S, Prat F, Barret M. Outcomes of esophagectomy after noncurative endoscopic resection of early esophageal cancer. Therap Adv Gastroenterol. 2019;12:1756284819892556. [PMID: 31839807 DOI: 10.1177/1756284819892556] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
55 Esaki M, Minoda Y, Ihara E, Sakisaka S, Tsuruta S, Hosokawa T, Wada M, Hata Y, Suzuki S, Iwao A, Yamakawa S, Irie A, Akiho H, Ogawa Y. Efficacy of traction, using a clip-with-thread, for esophageal endoscopic submucosal dissection for esophageal lesions with fibrosis in an ex vivo pig training model. Turk J Gastroenterol 2020;31:58-64. [PMID: 32009615 DOI: 10.5152/tjg.2020.19207] [Reference Citation Analysis]
56 Liu B, Bo Y, Wang K, Liu Y, Tang X, Zhao Y, Zhao E, Yuan L. Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials. Oncotarget 2017;8:20410-7. [PMID: 28099899 DOI: 10.18632/oncotarget.14669] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
57 Tanaka Y, Yoshida K, Tanahashi T, Okumura N, Matsuhashi N, Yamaguchi K. Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma. Cancer Sci 2016;107:764-72. [PMID: 27061001 DOI: 10.1111/cas.12943] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
58 Hamai Y, Hihara J, Emi M, Aoki Y, Okada M. Esophageal reconstruction using the terminal ileum and right colon in esophageal cancer surgery. Surg Today. 2012;42:342-350. [PMID: 22200754 DOI: 10.1007/s00595-011-0103-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
59 Adenis A, Tresch E, Dewas S, Romano O, Messager M, Amela E, Clisant S, Kramar A, Mariette C, Mirabel X. Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome. BMC Cancer 2013;13:413. [PMID: 24010566 DOI: 10.1186/1471-2407-13-413] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
60 Takahashi K, Nishikawa K, Furukawa K, Tanishima Y, Ishikawa Y, Kurogochi T, Yuda M, Tanaka Y, Matsumoto A, Mitsumori N, Ikegami T. Prognostic Significance of Preoperative Osteopenia in Patients Undergoing Esophagectomy for Esophageal Cancer. World J Surg 2021;45:3119-28. [PMID: 34152448 DOI: 10.1007/s00268-021-06199-w] [Reference Citation Analysis]
61 Cai XW, Yu WW, Yu W, Zhang Q, Feng W, Liu MN, Sun MH, Xiang JQ, Zhang YW, Fu XL. Tissue-based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma. Cancer Med. 2018;7:2504-2517. [PMID: 29683265 DOI: 10.1002/cam4.1463] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
62 Wullstein C, Ro-Papanikolaou HY, Klingebiel C, Ersahin K, Carolus R. Minimally Invasive Techniques and Hybrid Operations for Esophageal Cancer. Viszeralmedizin 2015;31:331-6. [PMID: 26989388 DOI: 10.1159/000438661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
63 Jung HK, Tae CH, Lee HA, Lee H, Don Choi K, Park JC, Kwon JG, Choi YJ, Hong SJ, Sung J, Chung WC, Kim KB, Kim SY, Song KH, Park KS, Jeon SW, Kim BW, Ryu HS, Lee OJ, Baik GH, Kim YS, Jung HY; Korean College of Helicobacter and Upper Gastrointestinal Research. Treatment pattern and overall survival in esophageal cancer during a 13-year period: A nationwide cohort study of 6,354 Korean patients. PLoS One 2020;15:e0231456. [PMID: 32275699 DOI: 10.1371/journal.pone.0231456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
64 Chen Y, Cheng X, Song H, Wu AJ, Ku GY, Lee P, Slingerland M, Koyanagi K, Ke S, Qiu H, Shi W, Gao Y, Chen J; written on behalf of AME Radiation Oncology Collaborative Group. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for esophageal squamous cell cancer patients presenting with oligometastases. J Thorac Dis 2019;11:1536-45. [PMID: 31179097 DOI: 10.21037/jtd.2019.03.10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
65 Li DJ, Shi M, Wang Z. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway. Thorac Cancer 2016;7:570-80. [PMID: 27766776 DOI: 10.1111/1759-7714.12370] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
66 Vellayappan BA, Soon YY, Ku GY, Leong CN, Lu JJ, Tey JC. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer. Cochrane Database Syst Rev 2017;8:CD010511. [PMID: 28829911 DOI: 10.1002/14651858.CD010511.pub2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
67 He H, Li S, Hong Y, Zou H, Chen H, Ding F, Wan Y, Liu Z. Krüppel-like Factor 4 Promotes Esophageal Squamous Cell Carcinoma Differentiation by Up-regulating Keratin 13 Expression. J Biol Chem 2015;290:13567-77. [PMID: 25851906 DOI: 10.1074/jbc.M114.629717] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
68 Ma DY, Tan BX, Liu M, Li XF, Zhou YQ, Lu Y. Concurrent three-dimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients with esophageal squamous cell carcinoma: a phase 2 single-institution study. Radiat Oncol 2014;9:28. [PMID: 24438695 DOI: 10.1186/1748-717X-9-28] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
69 Thumallapally N, Meshref A, Mousa M, Hendawi M, Lan M, Salem AI, Forte F. Survival benefit of neoadjuvant versus adjuvant radiotherapy in lymph node positive esophageal cancer: a population based analysis. J Gastrointest Oncol 2017;8:825-32. [PMID: 29184686 DOI: 10.21037/jgo.2017.06.19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
70 Hu X, Lin J, Jiang M, He X, Wang K, Wang W, Hu C, Shen Z, He Z, Lin H, Wu D, Wang M. HIF-1α Promotes the Metastasis of Esophageal Squamous Cell Carcinoma by Targeting SP1. J Cancer 2020;11:229-40. [PMID: 31892989 DOI: 10.7150/jca.35537] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
71 So H, Ahn JY, Han S, Jung K, Na HK, Lee JH, Jeong KW, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY. Efficacy and Safety of Fully Covered Self-Expanding Metal Stents for Malignant Esophageal Obstruction. Dig Dis Sci 2018;63:234-41. [PMID: 29147877 DOI: 10.1007/s10620-017-4839-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
72 Qiu G, Zhang H, Wang F, Zheng Y, Wang Z, Wang Y. Metastasis Patterns and Prognosis of Elderly Patients With Esophageal Adenocarcinoma in Stage IVB: A Population-Based Study. Front Oncol 2021;11:625720. [PMID: 34123784 DOI: 10.3389/fonc.2021.625720] [Reference Citation Analysis]
73 Mimura K, Yamada L, Ujiie D, Hayase S, Tada T, Hanayama H, Thar Min AK, Shibata M, Momma T, Saze Z, Ohki S, Kono K. Immunotherapy for esophageal squamous cell carcinoma: a review. Fukushima J Med Sci 2018;64:46-53. [PMID: 30058598 DOI: 10.5387/fms.2018-09] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
74 Briez N, Piessen G, Bonnetain F, Brigand C, Carrere N, Collet D, Doddoli C, Flamein R, Mabrut JY, Meunier B, Msika S, Perniceni T, Peschaud F, Prudhomme M, Triboulet JP, Mariette C. Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial. BMC Cancer. 2011;11:310. [PMID: 21781337 DOI: 10.1186/1471-2407-11-310] [Cited by in Crossref: 105] [Cited by in F6Publishing: 86] [Article Influence: 10.5] [Reference Citation Analysis]
75 Umemura A, Akiyama Y, Iwaya T, Koeda K, Sugimoto R, Sugai T, Endo F, Baba S, Nikai H, Nitta H, Takahara T, Otuska K, Kimura T, Saito H, Deguchi H, Tomoyasu M, Sasaki A. Super-late pulmonary recurrence after radical esophagectomy for esophageal squamous cell carcinoma. Int J Surg Case Rep 2020;72:166-71. [PMID: 32535535 DOI: 10.1016/j.ijscr.2020.05.068] [Reference Citation Analysis]
76 Osawa S, Furuta T, Sugimoto K, Kosugi T, Terai T, Yamade M, Takayanagi Y, Nishino M, Hamaya Y, Kodaira C, Yamada T, Iwaizumi M, Takagaki K, Yoshida K, Kanaoka S, Ikuma M. Prospective study of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma. BMC Cancer 2009;9:408. [PMID: 19930599 DOI: 10.1186/1471-2407-9-408] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
77 Manigrasso M, Vertaldi S, Marello A, Antoniou SA, Francis NK, De Palma GD, Milone M. Robotic Esophagectomy. A Systematic Review with Meta-Analysis of Clinical Outcomes. J Pers Med 2021;11:640. [PMID: 34357107 DOI: 10.3390/jpm11070640] [Reference Citation Analysis]
78 van der Sluis PC, Tagkalos E, Hadzijusufovic E, Babic B, Uzun E, van Hillegersberg R, Lang H, Grimminger PP. Robot-Assisted Minimally Invasive Esophagectomy with Intrathoracic Anastomosis (Ivor Lewis): Promising Results in 100 Consecutive Patients (the European Experience). J Gastrointest Surg 2021;25:1-8. [PMID: 32072382 DOI: 10.1007/s11605-019-04510-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
79 Klevebro F, Boshier PR, Low DE. Application of standardized hemodynamic protocols within enhanced recovery after surgery programs to improve outcomes associated with anastomotic leak and conduit necrosis in patients undergoing esophagectomy. J Thorac Dis 2019;11:S692-701. [PMID: 31080646 DOI: 10.21037/jtd.2018.11.141] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
80 Sun L, Zhang H, Wu K. Esophageal Cancer: Current Options for Therapeutic Management. Gastrointest Tumors 2014;1:105-13. [PMID: 26674591 DOI: 10.1159/000362907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
81 Mariette C, Renaud F, Piessen G, Gele P, Copin MC, Leteurtre E, Delaeter C, Dib M, Clisant S, Harter V, Bonnetain F, Duhamel A, Christophe V, Adenis A; Fregat Working Group. The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers. BMC Cancer 2018;18:139. [PMID: 29409462 DOI: 10.1186/s12885-018-3991-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
82 Lin CH, Li HY, Liu YP, Kuo PF, Wang WC, Lin FC, Chang WL, Sheu BS, Wang YC, Hung WC, Cheng HC, Yao YC, Calkins MJ, Hsiao M, Lu PJ. High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma. Ther Adv Med Oncol 2019;11:1758835919875324. [PMID: 31632466 DOI: 10.1177/1758835919875324] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
83 Chen HS, Hung WH, Ko JL, Hsu PK, Liu CC, Wu SC, Lin CH, Wang BY. Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan. Medicine (Baltimore) 2016;95:e3018. [PMID: 26962818 DOI: 10.1097/MD.0000000000003018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
84 Lindner K, Fritz M, Haane C, Senninger N, Palmes D, Hummel R. Postoperative complications do not affect long-term outcome in esophageal cancer patients. World J Surg 2014;38:2652-61. [PMID: 24867467 DOI: 10.1007/s00268-014-2590-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
85 Chen HY, Ma XM, Ye M, Hou YL, Xie HY, Bai YR. Esophageal perforation during or after conformal radiotherapy for esophageal carcinoma. J Radiat Res 2014;55:940-7. [PMID: 24914102 DOI: 10.1093/jrr/rru031] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
86 Ma S, Yan T, Liu D, Wang K, Wang J, Song J, Wang T, He W, Bai J, Jin L, Chen X. Neoadjuvant chemotherapy followed by minimally invasive esophagectomy is safe and feasible for treatment of esophageal squamous cell carcinoma. Thorac Cancer 2018;9:310-5. [PMID: 29319236 DOI: 10.1111/1759-7714.12590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
87 Diakowska D. Cytokines association with clinical and pathological changes in esophageal squamous cell carcinoma. Dis Markers 2013;35:883-93. [PMID: 24427776 DOI: 10.1155/2013/302862] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
88 Kranzfelder M, Seidl S, Dobritz M, Brücher BL. Amelanotic esophageal malignant melanoma: case report and short review of the literature. Case Rep Gastroenterol 2008;2:224-31. [PMID: 21327177 DOI: 10.1159/000137376] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
89 van der Sluis PC, Ruurda JP, van der Horst S, Verhage RJ, Besselink MG, Prins MJ, Haverkamp L, Schippers C, Rinkes IH, Joore HC. Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial). Trials. 2012;13:230. [PMID: 23199187 DOI: 10.1186/1745-6215-13-230] [Cited by in Crossref: 105] [Cited by in F6Publishing: 88] [Article Influence: 11.7] [Reference Citation Analysis]
90 Li R, Chen BL, Zhou YW, Guo RW, Shuai MT, Zeng JX, Leng AM. Expression and clinical significance of Apollon in esophageal squamous cell carcinoma. Mol Med Rep 2016;14:1933-40. [PMID: 27432467 DOI: 10.3892/mmr.2016.5473] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
91 Weng L, Shen S, Wu S, Yin X, Liu B, Shang M, Zou X, Mao A. Identification of Critical Genes and Proteins for Stent Restenosis Induced by Esophageal Benign Hyperplasia in Esophageal Cancer. Front Genet 2020;11:563954. [PMID: 33391336 DOI: 10.3389/fgene.2020.563954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
92 Mortensen MB, Fristrup C, Ainsworth A, Nielsen HO, Pless T, Hovendal C. Combined pretherapeutic endoscopic and laparoscopic ultrasonography may predict survival of patients with upper gastrointestinal tract cancer. Surg Endosc. 2011;25:804-812. [PMID: 20676688 DOI: 10.1007/s00464-010-1258-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
93 Su XD, Zhang DK, Zhang X, Lin P, Long H, Rong TH. Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma. J Thorac Dis. 2014;6:949-957. [PMID: 25093092 DOI: 10.3978/j.issn.2072-1439.2014.07.14] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
94 Er P, Qian D, Zhang W, Zhang B, Wei H, Zhang T, Chen X, Wang Y, Zhao J, Wang Q, Pang Q, Wang P. The expression of PDGF-BB predicts curative effect in locally advanced esophageal squamous cell carcinoma treated by radiotherapy. Aging (Albany NY) 2020;12:6586-99. [PMID: 32330901 DOI: 10.18632/aging.102993] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Xin Z, Xin G, Shi M, Song L, Wang Q, Jiang B, Liu X. Inhibition of MUC1-C entering nuclear suppresses MYC expression and attenuates malignant growth in esophageal squamous cell carcinoma. Onco Targets Ther 2018;11:4125-36. [PMID: 30050304 DOI: 10.2147/OTT.S168813] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
96 Blanchard P, Quero L, Pacault V, Schlageter MH, Baruch-Hennequin V, Hennequin C. Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy. BMC Cancer. 2012;12:119. [PMID: 22448886 DOI: 10.1186/1471-2407-12-119] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
97 Fan C, Yang Y, Liu Y, Jiang S, Di S, Hu W, Ma Z, Li T, Zhu Y, Xin Z, Wu G, Han J, Li X, Yan X. Icariin displays anticancer activity against human esophageal cancer cells via regulating endoplasmic reticulum stress-mediated apoptotic signaling. Sci Rep 2016;6:21145. [PMID: 26892033 DOI: 10.1038/srep21145] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 8.4] [Reference Citation Analysis]
98 Li Z, Cheng J, Zhang Y, Wen S, Lv H, Xu Y, Zhu Y, Zhang Z, Mu D, Tian Z. Comparison of Up-Front Minimally Invasive Esophagectomy versus Open Esophagectomy on Quality of Life for Esophageal Squamous Cell Cancer. Curr Oncol 2021;28:693-701. [PMID: 33503901 DOI: 10.3390/curroncol28010068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Liu J, Yue J, Xing L, Yu J. Present status and progress of neoadjuvant chemoradiotherapy for esophageal cancer. Front Med. 2013;7:172-179. [PMID: 23681891 DOI: 10.1007/s11684-013-0268-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
100 Jarral OA, Purkayastha S, Athanasiou T, Darzi A, Hanna GB, Zacharakis E. Thoracoscopic esophagectomy in the prone position. Surg Endosc. 2012;26:2095-2103. [PMID: 22395952 DOI: 10.1007/s00464-012-2172-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
101 Xie CY, Hu YH, Ho JW, Han LJ, Yang H, Wen J, Lam KO, Wong IY, Law SY, Chiu KW, Fu JH, Vardhanabhuti V. Using Genomics Feature Selection Method in Radiomics Pipeline Improves Prognostication Performance in Locally Advanced Esophageal Squamous Cell Carcinoma-A Pilot Study. Cancers (Basel) 2021;13:2145. [PMID: 33946826 DOI: 10.3390/cancers13092145] [Reference Citation Analysis]
102 Xin Z, Song X, Jiang B, Gongsun X, Song L, Qin Q, Wang Q, Shi M, Liu X. Blocking FGFR4 exerts distinct anti-tumorigenic effects in esophageal squamous cell carcinoma. Thorac Cancer 2018;9:1687-98. [PMID: 30267473 DOI: 10.1111/1759-7714.12883] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
103 GongSun X, Zhao Y, Jiang B, Xin Z, Shi M, Song L, Qin Q, Wang Q, Liu X. Inhibition of MUC1-C regulates metabolism by AKT pathway in esophageal squamous cell carcinoma. J Cell Physiol 2019;234:12019-28. [PMID: 30523643 DOI: 10.1002/jcp.27863] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
104 Moriya H, Ohbu M, Kobayashi N, Tanabe S, Katada N, Futawatari N, Sakuramoto S, Kikuchi S, Okayasu I, Watanabe M. Lymphatic tumor emboli detected by D2-40 immunostaining can more accurately predict lymph-node metastasis. World J Surg. 2011;35:2031-2037. [PMID: 21667194 DOI: 10.1007/s00268-011-1143-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
105 Yin MP, Xie PF, Zhao Y, He W, Ma YZ, Li CX, Li Z, Zeng YW, Wu G. Clinical Evaluation of Transarterial Infusion Chemotherapy for Advanced Esophageal Cancer. J Cancer 2021;12:1493-8. [PMID: 33531994 DOI: 10.7150/jca.46877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
106 Buergy D, Lohr F, Baack T, Siebenlist K, Haneder S, Michaely H, Wenz F, Boda-Heggemann J. Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy. Radiat Oncol. 2012;7:192. [PMID: 23157945 DOI: 10.1186/1748-717x-7-192] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
107 Chen SB, Weng HR, Wang G, Yang JS, Yang WP, Liu DT, Chen YP, Zhang H. Primary adenosquamous carcinoma of the esophagus. World J Gastroenterol. 2013;19:8382-8390. [PMID: 24363531 DOI: 10.3748/wjg.v19.i45.8382] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
108 Ma MW, Gao XS, Gu XB, Xie M, Cui M, Zhang M, Liu L, Yin H, Chen LQ. The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma. World J Surg Oncol 2018;16:172. [PMID: 30119684 DOI: 10.1186/s12957-018-1470-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
109 Wolf MC, Stahl M, Krause BJ, Bonavina L, Bruns C, Belka C, Zehentmayr F. Curative treatment of oesophageal carcinoma: current options and future developments. Radiat Oncol. 2011;6:55. [PMID: 21615894 DOI: 10.1186/1748-717x-6-55] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
110 Liu J, Li F, Ping Y, Wang L, Chen X, Wang D, Cao L, Zhao S, Li B, Kalinski P. Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma. Oncotarget. 2015;6:24978-24989. [PMID: 26317795 DOI: 10.18632/oncotarget.4617] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 9.8] [Reference Citation Analysis]
111 Wang Q, Zhang W, Liu X, Zhang X, He J, Feng Q, Zhou Z, Wang L, Yin W, Xiao Z. Prognosis of esophageal squamous cell carcinoma patients with preoperative radiotherapy: Comparison of different cancer staging systems. Thorac Cancer 2014;5:204-10. [PMID: 26767002 DOI: 10.1111/1759-7714.12079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
112 Shi M, Chen D, Yang D, Liu XY. CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1. J Exp Clin Cancer Res 2015;34:149. [PMID: 26667143 DOI: 10.1186/s13046-015-0268-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
113 Park SY, Hong MH, Kim HR, Lee CG, Cho JH, Cho BC, Kim DJ. The feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma. J Thorac Dis 2020;12:6426-34. [PMID: 33282345 DOI: 10.21037/jtd-20-1088] [Cited by in F6Publishing: 1] [Reference Citation Analysis]